{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:15:51Z","timestamp":1778793351875,"version":"3.51.4"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T00:00:00Z","timestamp":1225929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00439-008-0583-8","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T22:57:48Z","timestamp":1225925868000},"page":"561-577","source":"Crossref","is-referenced-by-count":99,"title":["Advances in osteoclast biology resulting from the study of osteopetrotic mutations"],"prefix":"10.1007","volume":"124","author":[{"given":"T.","family":"Segovia-Silvestre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Neutzsky-Wulff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bollerslev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,6]]},"reference":[{"key":"583_CR1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1373\/clinchem.2003.029355","volume":"50","author":"SL Alatalo","year":"2004","unstructured":"Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Vaananen HK, Halleen JM (2004) Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin Chem 50:883\u2013890","journal-title":"Clin Chem"},{"key":"583_CR2","unstructured":"Albers-Sch\u00f6nberg HE (1904) R\u00f6ntgenbilder einer seltenen Knockenerkrankung. Munch Med Wochenschr 5:365\u2013368"},{"key":"583_CR3","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","volume":"190","author":"F Arai","year":"1999","unstructured":"Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T (1999) Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 190:1741\u20131754","journal-title":"J Exp Med"},{"key":"583_CR4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jbmr.5650090720","volume":"9","author":"S Asotra","year":"1994","unstructured":"Asotra S, Gupta AK, Sodek J, Aubin JE, Heersche JN (1994) Carbonic anhydrase II mRNA expression in individual osteoclasts under \u201cresorbing\u201d and \u201cnonresorbing\u201d conditions. J Bone Miner Res 9:1115\u20131122","journal-title":"J Bone Miner Res"},{"key":"583_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1010011209064","volume":"2","author":"JE Aubin","year":"2001","unstructured":"Aubin JE (2001) Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2:81\u201394","journal-title":"Rev Endocr Metab Disord"},{"key":"583_CR6","unstructured":"Aubin, Lian JB, Stein GS (2006) Bone formation: maturation and functional activities of osteoblast lineage cell., 6th edn, pp 20\u201329"},{"key":"583_CR7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00223-005-0027-6","volume":"77","author":"W Balemans","year":"2005","unstructured":"Balemans W, Van Wesenbeeck L, Van Hul W (2005) A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int 77:263\u2013274","journal-title":"Calcif Tissue Int"},{"key":"583_CR8","unstructured":"Baron (2005) General principles of bone biology, 5th edn, pp 1\u20138"},{"key":"583_CR9","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1083\/jcb.101.6.2210","volume":"101","author":"R Baron","year":"1985","unstructured":"Baron R, Neff L, Louvard D, Courtoy PJ (1985) Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101:2210\u20132222","journal-title":"J Cell Biol"},{"issue":"Suppl 2","key":"583_CR10","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1002\/jbmr.5650081326","volume":"8","author":"DJ Baylink","year":"1993","unstructured":"Baylink DJ, Finkelman RD, Mohan S (1993) Growth factors to stimulate bone formation. J Bone Miner Res 8(Suppl 2):S565\u2013S572","journal-title":"J Bone Miner Res"},{"key":"583_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","volume":"26","author":"OD Benichou","year":"2000","unstructured":"Benichou OD, Laredo JD, de Vernejoul MC (2000) Type II autosomal dominant osteopetrosis (Albers\u2013Schonberg disease): clinical and radiological manifestations in 42 patients. Bone 26:87\u201393","journal-title":"Bone"},{"key":"583_CR12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/323132","volume":"69","author":"O Benichou","year":"2001","unstructured":"Benichou O, Cleiren E, Gram J, Bollerslev J, de Vernejoul MC, Van Hul W (2001) Mapping of autosomal dominant osteopetrosis type II (Albers\u2013Schonberg disease) to chromosome 16p13.3. Am J Hum Genet 69:647\u2013654","journal-title":"Am J Hum Genet"},{"key":"583_CR13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","volume":"349","author":"DM Black","year":"2003","unstructured":"Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ (2003) The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349:1207\u20131215","journal-title":"N Engl J Med"},{"key":"583_CR14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1126\/science.2528207","volume":"245","author":"HC Blair","year":"1989","unstructured":"Blair HC, Teitelbaum SL, Ghiselli R, Gluck S (1989) Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 245:855\u2013857","journal-title":"Science"},{"key":"583_CR15","doi-asserted-by":"crossref","first-page":"C1315","DOI":"10.1152\/ajpcell.1991.260.6.C1315","volume":"260","author":"HC Blair","year":"1991","unstructured":"Blair HC, Teitelbaum SL, Tan HL, Koziol CM, Schlesinger PH (1991) Passive chloride permeability charge coupled to H(+)-ATPase of avian osteoclast ruffled membrane. Am J Physiol 260:C1315\u2013C1324","journal-title":"Am J Physiol"},{"key":"583_CR16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1359\/JBMR.040403","volume":"19","author":"HC Blair","year":"2004","unstructured":"Blair HC, Borysenko CW, Villa A, Schlesinger PH, Kalla SE, Yaroslavskiy BB, Garcia-Palacios V, Oakley JI, Orchard PJ (2004) In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects. J Bone Miner Res 19:1329\u20131338","journal-title":"J Bone Miner Res"},{"key":"583_CR17","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/sj.leu.2403449","volume":"18","author":"C Blin-Wakkach","year":"2004","unstructured":"Blin-Wakkach C, Wakkach A, Sexton PM, Rochet N, Carle GF (2004) Hematological defects in the oc\/oc mouse, a model of infantile malignant osteopetrosis. Leukemia 18:1505\u20131511","journal-title":"Leukemia"},{"key":"583_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/edrv-10-1-45","volume":"10","author":"J Bollerslev","year":"1989","unstructured":"Bollerslev J (1989) Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects. Endocr Rev 10:45\u201367","journal-title":"Endocr Rev"},{"key":"583_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1288\/00005537-198804000-00011","volume":"98","author":"J Bollerslev","year":"1988","unstructured":"Bollerslev J, Grontved A, Andersen PE Jr (1988) Autosomal dominant osteopetrosis: an otoneurological investigation of the two radiological types. Laryngoscope 98:411\u2013413","journal-title":"Laryngoscope"},{"key":"583_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/8756-3282(89)90142-7","volume":"10","author":"J Bollerslev","year":"1989","unstructured":"Bollerslev J, Steiniche T, Melsen F, Mosekilde L (1989) Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types. Bone 10:19\u201324","journal-title":"Bone"},{"key":"583_CR21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/8756-3282(93)90316-3","volume":"14","author":"J Bollerslev","year":"1993","unstructured":"Bollerslev J, Marks SC Jr, Pockwinse S, Kassem M, Brixen K, Steiniche T, Mosekilde L (1993) Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis. Bone 14:865\u2013869","journal-title":"Bone"},{"key":"583_CR22","doi-asserted-by":"crossref","unstructured":"Bollerslev J, Ueland T, Landaas S, Marks SC Jr. (2000) Serum creatine kinase isoenzyme BB in mammalian osteopetrosis. Clin Orthop Relat Res 241\u2013247","DOI":"10.1097\/00003086-200008000-00032"},{"key":"583_CR23","doi-asserted-by":"crossref","first-page":"12517","DOI":"10.1074\/jbc.271.21.12517","volume":"271","author":"MJ Bossard","year":"1996","unstructured":"Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M, Levy MA (1996) Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem 271:12517\u201312524","journal-title":"J Biol Chem"},{"key":"583_CR24","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513\u20131521","journal-title":"N Engl J Med"},{"key":"583_CR25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342","journal-title":"Nature"},{"key":"583_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-5793(95)01298-2","volume":"377","author":"S Brandt","year":"1995","unstructured":"Brandt S, Jentsch TJ (1995) ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family. FEBS Lett 377:15\u201320","journal-title":"FEBS Lett"},{"key":"583_CR27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S8756-3282(01)00619-6","volume":"30","author":"DB Burr","year":"2002","unstructured":"Burr DB (2002) Targeted and nontargeted remodeling. Bone 30:2\u20134","journal-title":"Bone"},{"key":"583_CR28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00439-002-0861-9","volume":"112","author":"AB Campos-Xavier","year":"2003","unstructured":"Campos-Xavier AB, Saraiva JM, Ribeiro LM, Munnich A, Cormier-Daire V (2003) Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis. Hum Genet 112:186\u2013189","journal-title":"Hum Genet"},{"key":"583_CR29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajmg.a.30490","volume":"133","author":"AB Campos-Xavier","year":"2005","unstructured":"Campos-Xavier AB, Casanova JL, Doumaz Y, Feingold J, Munnich A, Cormier-Daire V (2005) Intrafamilial phenotypic variability of osteopetrosis due to chloride channel 7 (CLCN7) mutations. Am J Med Genet A 133:216\u2013218","journal-title":"Am J Med Genet A"},{"key":"583_CR30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nm842","volume":"9","author":"N Chalhoub","year":"2003","unstructured":"Chalhoub N, Benachenhou N, Rajapurohitam V, Pata M, Ferron M, Frattini A, Villa A, Vacher J (2003) Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat Med 9:399\u2013406","journal-title":"Nat Med"},{"key":"583_CR31","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1359\/jbmr.080231","volume":"23","author":"P Chavassieux","year":"2008","unstructured":"Chavassieux P, Asser KM, Segovia-Silvestre T, Neutzsky-Wulff AV, Chapurlat R, Boivin G, Delmas PD (2008) Mechanisms of the anabolic effects of teriparatide on bone: insight from the treatment of a patient with pycnodysostosis. J Bone Miner Res 23:1076\u20131083","journal-title":"J Bone Miner Res"},{"key":"583_CR32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/hmg\/ddl474","volume":"16","author":"W Chen","year":"2007","unstructured":"Chen W, Yang S, Abe Y, Li M, Wang Y, Shao J, Li E, Li YP (2007) Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence. Hum Mol Genet 16:410\u2013423","journal-title":"Hum Mol Genet"},{"key":"583_CR33","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/hmg\/10.25.2861","volume":"10","author":"E Cleiren","year":"2001","unstructured":"Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T, deVernejoul MC, Van Hul W (2001) Albers\u2013Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 10:2861\u20132867","journal-title":"Hum Mol Genet"},{"key":"583_CR34","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/ajmg.a.31368","volume":"140","author":"MM Cohen Jr","year":"2006","unstructured":"Cohen MM Jr (2006) The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet A 140:2646\u20132706","journal-title":"Am J Med Genet A"},{"key":"583_CR35","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1359\/JBMR.040514","volume":"19","author":"XM Dai","year":"2004","unstructured":"Dai XM, Zong XH, Akhter MP, Stanley ER (2004) Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J Bone Miner Res 19:1441\u20131451","journal-title":"J Bone Miner Res"},{"key":"583_CR36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jmg.2005.036673","volume":"43","author":"A Del Fattore","year":"2006","unstructured":"Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M, Luciani M, Devito R, Pinto R, Caniglia M, Lanino E, Messina C, Cesaro S, Letizia C, Bianchini G, Fryssira H, Grabowski P, Shaw N, Bishop N, Hughes D, Kapur RP, Datta HK, Taranta A, Fornari R, Migliaccio S, Teti A (2006) Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet 43:315\u2013325","journal-title":"J Med Genet"},{"key":"583_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2007.08.029","volume":"42","author":"A Del Fattore","year":"2008","unstructured":"Del Fattore A, Cappariello A, Teti A (2008a) Genetics, pathogenesis and complications of osteopetrosis. Bone 42:19\u201329","journal-title":"Bone"},{"key":"583_CR38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1359\/jbmr.071107","volume":"23","author":"A Del Fattore","year":"2008","unstructured":"Del Fattore A, Fornari R, Van Wesenbeeck L, de Freitas F, Timmermans JP, Peruzzi B, Cappariello A, Rucci N, Spera G, Helfrich MH, Van Hul W, Migliaccio S, Teti A (2008b) A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts. J Bone Miner Res 23:380\u2013391","journal-title":"J Bone Miner Res"},{"key":"583_CR39","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1210\/en.2002-220221","volume":"143","author":"B Demiralp","year":"2002","unstructured":"Demiralp B, Chen HL, Koh AJ, Keller ET, McCauley LK (2002) Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology 143:4038\u20134047","journal-title":"Endocrinology"},{"key":"583_CR40","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jbmr.5650101109","volume":"10","author":"RA Dodds","year":"1995","unstructured":"Dodds RA, Connor JR, James IE, Rykaczewski EL, Appelbaum E, Dul E, Gowen M (1995) Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone. J Bone Miner Res 10:1666\u20131680","journal-title":"J Bone Miner Res"},{"key":"583_CR41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/humu.9490","volume":"28","author":"M Donnarumma","year":"2007","unstructured":"Donnarumma M, Regis S, Tappino B, Rosano C, Assereto S, Corsolini F, Di Rocco M, Filocamo M (2007) Molecular analysis and characterization of nine novel CTSK mutations in twelve patients affected by pycnodysostosis. Mutation in brief #961. Online. Hum Mutat 28:524","journal-title":"Hum Mutat"},{"key":"583_CR42","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1074\/jbc.271.21.12511","volume":"271","author":"FH Drake","year":"1996","unstructured":"Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G, Gowen M (1996) Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511\u201312516","journal-title":"J Biol Chem"},{"key":"583_CR43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1704194","volume":"32","author":"GJ Driessen","year":"2003","unstructured":"Driessen GJ, Gerritsen EJ, Fischer A, Fasth A, Hop WC, Veys P, Porta F, Cant A, Steward CG, Vossen JM, Uckan D, Friedrich W (2003) Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant 32:657\u2013663","journal-title":"Bone Marrow Transplant"},{"key":"583_CR44","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.289.5484.1501","volume":"289","author":"P Ducy","year":"2000","unstructured":"Ducy P, Schinke T, Karsenty G (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501\u20131504","journal-title":"Science"},{"key":"583_CR45","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1542\/peds.109.6.e97","volume":"109","author":"S Dupuis-Girod","year":"2002","unstructured":"Dupuis-Girod S, Corradini N, Hadj-Rabia S, Fournet JC, Faivre L, Le Deist F, Durand P, Doffinger R, Smahi A, Israel A, Courtois G, Brousse N, Blanche S, Munnich A, Fischer A, Casanova JL, Bodemer C (2002) Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 109:e97","journal-title":"Pediatrics"},{"key":"583_CR46","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","volume":"111","author":"G Eghbali-Fatourechi","year":"2003","unstructured":"Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221\u20131230","journal-title":"J Clin Invest"},{"key":"583_CR47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02557674","volume":"37","author":"V Everts","year":"1985","unstructured":"Everts V, Aronson DC, Beertsen W (1985) Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis. Calcif Tissue Int 37:25\u201331","journal-title":"Calcif Tissue Int"},{"key":"583_CR48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1359\/jbmr.2002.17.1.77","volume":"17","author":"V Everts","year":"2002","unstructured":"Everts V, Delaisse JM, Korper W, Jansen DC, Tigchelaar-Gutter W, Saftig P, Beertsen W (2002) The bone lining cell: its role in cleaning Howship\u2019s lacunae and initiating bone formation. J Bone Miner Res 17:77\u201390","journal-title":"J Bone Miner Res"},{"key":"583_CR49","unstructured":"Favus MJ, Bushinsky DA, Lemann J (2006) Regulation of calcium, magnesium, and phosphate metabolism. In: Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th edn, Chap 13, pp 76\u201383"},{"key":"583_CR50","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.cellsig.2008.01.009","volume":"20","author":"ME Feigin","year":"2008","unstructured":"Feigin ME, Malbon CC (2008) OSTM1 regulates beta-catenin\/Lef1 interaction and is required for Wnt\/beta-catenin signaling. Cell Signal 20:949\u2013957","journal-title":"Cell Signal"},{"key":"583_CR51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2007-979005","volume":"29","author":"DM Findlay","year":"1997","unstructured":"Findlay DM, Martin TJ (1997) Receptors of calciotropic hormones. Horm Metab Res 29:128\u2013134","journal-title":"Horm Metab Res"},{"key":"583_CR52","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","volume":"349","author":"JS Finkelstein","year":"2003","unstructured":"Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349:1216\u20131226","journal-title":"N Engl J Med"},{"key":"583_CR53","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1073\/pnas.1432965100","volume":"100","author":"T Fischer","year":"2003","unstructured":"Fischer T, De Vries L, Meerloo T, Farquhar MG (2003) Promotion of G alpha i3 subunit down-regulation by GIPN, a putative E3 ubiquitin ligase that interacts with RGS-GAIP. Proc Natl Acad Sci USA 100:8270\u20138275","journal-title":"Proc Natl Acad Sci USA"},{"key":"583_CR54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1359\/jbmr.2000.15.2.352","volume":"15","author":"AM Flanagan","year":"2000","unstructured":"Flanagan AM, Sarma U, Steward CG, Vellodi A, Horton MA (2000) Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis. J Bone Miner Res 15:352\u2013360","journal-title":"J Bone Miner Res"},{"key":"583_CR55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/77131","volume":"25","author":"A Frattini","year":"2000","unstructured":"Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A (2000) Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 25:343\u2013346","journal-title":"Nat Genet"},{"key":"583_CR56","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1359\/jbmr.2003.18.10.1740","volume":"18","author":"A Frattini","year":"2003","unstructured":"Frattini A, Pangrazio A, Susani L, Sobacchi C, Mirolo M, Abinun M, Andolina M, Flanagan A, Horwitz EM, Mihci E, Notarangelo LD, Ramenghi U, Teti A, Van Hove J, Vujic D, Young T, Albertini A, Orchard PJ, Vezzoni P, Villa A (2003) Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res 18:1740\u20131747","journal-title":"J Bone Miner Res"},{"key":"583_CR57","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/jc.2003-031055","volume":"89","author":"N Fratzl-Zelman","year":"2004","unstructured":"Fratzl-Zelman N, Valenta A, Roschger P, Nader A, Gelb BD, Fratzl P, Klaushofer K (2004) Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J Clin Endocrinol Metab 89:1538\u20131547","journal-title":"J Clin Endocrinol Metab"},{"key":"583_CR58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jcem.85.1.6247","volume":"85","author":"Y Fujita","year":"2000","unstructured":"Fujita Y, Nakata K, Yasui N, Matsui Y, Kataoka E, Hiroshima K, Shiba RI, Ochi T (2000) Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization. J Clin Endocrinol Metab 85:425\u2013431","journal-title":"J Clin Endocrinol Metab"},{"key":"583_CR59","doi-asserted-by":"crossref","first-page":"32347","DOI":"10.1074\/jbc.273.48.32347","volume":"273","author":"P Garnero","year":"1998","unstructured":"Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaisse JM (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273:32347\u201332352","journal-title":"J Biol Chem"},{"key":"583_CR60","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1359\/jbmr.2003.18.5.859","volume":"18","author":"P Garnero","year":"2003","unstructured":"Garnero P, Ferreras M, Karsdal MA, NicAmhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaisse JM (2003) The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 18:859\u2013867","journal-title":"J Bone Miner Res"},{"key":"583_CR61","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.273.5279.1236","volume":"273","author":"BD Gelb","year":"1996","unstructured":"Gelb BD, Shi GP, Chapman HA, Desnick RJ (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236\u20131238","journal-title":"Science"},{"key":"583_CR62","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(05)82004-9","volume":"125","author":"EJ Gerritsen","year":"1994","unstructured":"Gerritsen EJ, Vossen JM, Fasth A, Friedrich W, Morgan G, Padmos A, Vellodi A, Porras O, O\u2019Meara A, Porta F (1994a) Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr 125:896\u2013902","journal-title":"J Pediatr"},{"key":"583_CR63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1542\/peds.93.2.247","volume":"93","author":"EJ Gerritsen","year":"1994","unstructured":"Gerritsen EJ, Vossen JM, van Loo IH, Hermans J, Helfrich MH, Griscelli C, Fischer A (1994b) Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics 93:247\u2013253","journal-title":"Pediatrics"},{"key":"583_CR64","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1359\/jbmr.1999.14.10.1654","volume":"14","author":"M Gowen","year":"1999","unstructured":"Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I (1999) Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654\u20131663","journal-title":"J Bone Miner Res"},{"key":"583_CR65","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF02556458","volume":"48","author":"J Gram","year":"1991","unstructured":"Gram J, Antonsen S, Horder M, Bollerslev J (1991) Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II. Calcif Tissue Int 48:438\u2013439","journal-title":"Calcif Tissue Int"},{"key":"583_CR66","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature06907","volume":"453","author":"AR Graves","year":"2008","unstructured":"Graves AR, Curran PK, Smith CL, Mindell JA (2008) The Cl(\u2212)\/H(+) antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 453:788\u2013792","journal-title":"Nature"},{"key":"583_CR67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2008.06.015","volume":"83","author":"MM Guerrini","year":"2008","unstructured":"Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, Moratto D, Mazzolari E, Clayton-Smith J, Orchard P, Coxon FP, Helfrich MH, Crockett JC, Mellis D, Vellodi A, Tezcan I, Notarangelo LD, Rogers MJ, Vezzoni P, Villa A, Frattini A (2008) Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet 83:64\u201376","journal-title":"Am J Hum Genet"},{"key":"583_CR68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.ejhg.5200481","volume":"8","author":"A Haagerup","year":"2000","unstructured":"Haagerup A, Hertz JM, Christensen MF, Binderup H, Kruse TA (2000) Cathepsin K gene mutations and 1q21 haplotypes in at patients with pycnodysostosis in an outbred population. Eur J Hum Genet 8:431\u2013436","journal-title":"Eur J Hum Genet"},{"key":"583_CR69","unstructured":"Hannon RA, Clack G, Gallager N, Macpherson M, Marshall A, Eastell R (2005) The effect of AZ0530, a highly selective SRC inhibitor, on bone turnover in healthy males. Bone 36:Suppl 2 (Abstract nb OC042)"},{"key":"583_CR70","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1532-5415.2004.52218.x","volume":"52","author":"H Hansdottir","year":"2004","unstructured":"Hansdottir H, Franzson L, Prestwood K, Sigurdsson G (2004) The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities. J Am Geriatr Soc 52:779\u2013783","journal-title":"J Am Geriatr Soc"},{"key":"583_CR71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/206489a0","volume":"206","author":"R Hattner","year":"1965","unstructured":"Hattner R, Epker BN, Frost HM (1965) Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature 206:489\u2013490","journal-title":"Nature"},{"key":"583_CR72","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1016\/8756-3282(95)00186-H","volume":"17","author":"JM Hayden","year":"1995","unstructured":"Hayden JM, Mohan S, Baylink DJ (1995) The insulin-like growth factor system and the coupling of formation to resorption. Bone 17:93S\u201398S","journal-title":"Bone"},{"key":"583_CR73","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1242\/dev.122.10.3151","volume":"122","author":"AR Hayman","year":"1996","unstructured":"Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, Cox TM (1996) Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122:3151\u20133162","journal-title":"Development"},{"key":"583_CR74","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/7.9.1407","volume":"7","author":"C Heaney","year":"1998","unstructured":"Heaney C, Shalev H, Elbedour K, Carmi R, Staack JB, Sheffield VC, Beier DR (1998) Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation. Hum Mol Genet 7:1407\u20131410","journal-title":"Hum Mol Genet"},{"key":"583_CR75","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jemt.10375","volume":"61","author":"MH Helfrich","year":"2003","unstructured":"Helfrich MH (2003) Osteoclast diseases. Microsc Res Tech 61:514\u2013532","journal-title":"Microsc Res Tech"},{"key":"583_CR76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2141.2001.02538.x","volume":"112","author":"MH Helfrich","year":"2001","unstructured":"Helfrich MH, Gerritsen EJ (2001) Formation of non-resorbing osteoclasts from peripheral blood mononuclear cells of patients with malignant juvenile osteopetrosis. Br J Haematol 112:64\u201368","journal-title":"Br J Haematol"},{"key":"583_CR77","doi-asserted-by":"crossref","unstructured":"Helfrich M, Crockett JC, Hocking LJ, Coxon FP (2007) The pathogenesis of osteoclast diseases: some knowns, but still many unknowns. Bonekey Osteovision 4:61\u201377","DOI":"10.1138\/20060249"},{"key":"583_CR78","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0002-9440(10)63712-1","volume":"164","author":"K Henriksen","year":"2004","unstructured":"Henriksen K, Gram J, Schaller S, Dahl BH, Dziegiel MH, Bollerslev J, Karsdal MA (2004) Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol 164:1537\u20131545","journal-title":"Am J Pathol"},{"key":"583_CR79","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0002-9440(10)61221-7","volume":"167","author":"Gram J Henriksen","year":"2005","unstructured":"Henriksen Gram J, Hoegh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, Schaller S, Bollerslev J, Karsdal MA (2005) Osteoclasts from patients with Autosomal Dominant Osteopetrosis type I (ADOI) caused by a T253I mutation in LRP5 are normal in vitro, but have decreased resorption capacity in vivo. Am J Pathol 167:1341\u20131348","journal-title":"Am J Pathol"},{"key":"583_CR80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1359\/JBMR.050905","volume":"21","author":"K Henriksen","year":"2006","unstructured":"Henriksen K, Sorensen MG, Nielsen Rh, Gram J, Schaller S, Dziegiel MH, Everts V, Bollerslev J, Karsdal MA (2006) Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J Bone Miner Res 21:58\u201366","journal-title":"J Bone Miner Res"},{"key":"583_CR81","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1359\/jbmr.1999.14.10.1649","volume":"14","author":"N Ho","year":"1999","unstructured":"Ho N, Punturieri A, Wilkin D, Szabo J, Johnson M, Whaley J, Davis J, Clark A, Weiss S, Francomano C (1999) Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein. J Bone Miner Res 14:1649\u20131653","journal-title":"J Bone Miner Res"},{"key":"583_CR82","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2141.2003.04530.x","volume":"122","author":"MA Horton","year":"2003","unstructured":"Horton MA, Massey HM, Rosenberg N, Nicholls B, Seligsohn U, Flanagan AM (2003) Upregulation of osteoclast alpha2beta1 integrin compensates for lack of alphavbeta3 vitronectin receptor in Iraqi-Jewish-type Glanzmann thrombasthenia. Br J Haematol 122:950\u2013957","journal-title":"Br J Haematol"},{"key":"583_CR83","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI653","volume":"103","author":"WS Hou","year":"1999","unstructured":"Hou WS, Bromme D, Zhao Y, Mehler E, Dushey C, Weinstein H, Miranda CS, Fraga C, Greig F, Carey J, Rimoin DL, Desnick RJ, Gelb BD (1999) Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest 103:731\u2013738","journal-title":"J Clin Invest"},{"key":"583_CR84","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1073\/pnas.78.5.3204","volume":"78","author":"GA Howard","year":"1981","unstructured":"Howard GA, Bottemiller BL, Turner RT, Rader JI, Baylink DJ (1981) Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. Proc Natl Acad Sci USA 78:3204\u20133208","journal-title":"Proc Natl Acad Sci USA"},{"key":"583_CR85","first-page":"418","volume":"59","author":"WE Huffer","year":"1988","unstructured":"Huffer WE (1988) Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances. Lab Invest 59:418\u2013442","journal-title":"Lab Invest"},{"key":"583_CR86","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","volume":"3","author":"V Iotsova","year":"1997","unstructured":"Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:1285\u20131289","journal-title":"Nat Med"},{"key":"583_CR87","unstructured":"Jansen I, De Vries T, Ravesloot J, Everts V, Oude Elferink R (2006) Loss of anion exchanger 2 (Ae2) in mice results in osteopetrosis. J Bone Miner Res 21:Suppl 1 (Abstract 1256)"},{"key":"583_CR88","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/er.2004-0001","volume":"26","author":"K Janssens","year":"2005","unstructured":"Janssens K, ten Dijke P, Janssens S, Van Hul W (2005) Transforming growth factor-beta1 to the bone. Endocr Rev 26:743\u2013774","journal-title":"Endocr Rev"},{"key":"583_CR89","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1359\/JBMR.040816","volume":"19","author":"ML Johnson","year":"2004","unstructured":"Johnson ML, Harnish K, Nusse R, Van HW (2004) LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res 19:1749\u20131757","journal-title":"J Bone Miner Res"},{"key":"583_CR90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1138\/20060245","volume":"4","author":"Henriksen K Karsdal","year":"2007","unstructured":"Karsdal Henriksen K (2007) Osteoclasts control osteoblast activity. BoneKey-Osteovision 4:19\u201324","journal-title":"BoneKey-Osteovision"},{"key":"583_CR91","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0002-9440(10)62269-9","volume":"166","author":"MA Karsdal","year":"2005","unstructured":"Karsdal MA, Henriksen K, Sorensen MG, Gram J, Schaller S, Dziegiel MH, Heegaard AM, Christophersen P, Martin TJ, Christiansen C, Bollerslev J (2005) Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am J Pathol 166:467\u2013476","journal-title":"Am J Pathol"},{"key":"583_CR92","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/jbmr.070109","volume":"22","author":"MA Karsdal","year":"2007","unstructured":"Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K (2007) Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 22:487\u2013494","journal-title":"J Bone Miner Res"},{"key":"583_CR93","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbrc.2007.11.168","volume":"366","author":"MA Karsdal","year":"2008","unstructured":"Karsdal MA, Neutzsky-Wulff AV, Dziegiel MH, Christiansen C, Henriksen K (2008) Osteoclasts secrete non-bone derived signals that induce bone formation. Biochem Biophys Res Commun 366:483\u2013488","journal-title":"Biochem Biophys Res Commun"},{"key":"583_CR94","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.emboj.7600576","volume":"24","author":"D Kasper","year":"2005","unstructured":"Kasper D, Planells-Cases R, Fuhrmann JC, Scheel O, Zeitz O, Ruether K, Schmitt A, Poet M, Steinfeld R, Schweizer M, Kornak U, Jentsch TJ (2005) Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J 24:1079\u20131091","journal-title":"EMBO J"},{"key":"583_CR95","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bone.2004.09.020","volume":"36","author":"R Kiviranta","year":"2005","unstructured":"Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E (2005) Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL\/OPG ratio. Bone 36:159\u2013172","journal-title":"Bone"},{"key":"583_CR96","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molmed.2005.01.004","volume":"11","author":"MA Koay","year":"2005","unstructured":"Koay MA, Brown MA (2005) Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton. Trends Mol Med 11:129\u2013137","journal-title":"Trends Mol Med"},{"key":"583_CR97","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","volume":"428","author":"T Koga","year":"2004","unstructured":"Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758\u2013763","journal-title":"Nature"},{"key":"583_CR98","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1210\/en.2005-0333","volume":"146","author":"AJ Koh","year":"2005","unstructured":"Koh AJ, Demiralp B, Neiva KG, Hooten J, Nohutcu RM, Shim H, Datta NS, Taichman RS, McCauley LK (2005) Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. Endocrinology 146:4584\u20134596","journal-title":"Endocrinology"},{"key":"583_CR99","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/hmg\/9.13.2059","volume":"9","author":"U Kornak","year":"2000","unstructured":"Kornak U, Schulz A, Friedrich W, Uhlhaas S, Kremens B, Voit T, Hasan C, Bode U, Jentsch TJ, Kubisch C (2000) Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 9:2059\u20132063","journal-title":"Hum Mol Genet"},{"key":"583_CR100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(01)00206-9","volume":"104","author":"U Kornak","year":"2001","unstructured":"Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ (2001) Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104:205\u2013215","journal-title":"Cell"},{"key":"583_CR101","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"583_CR102","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1172\/JCI117235","volume":"93","author":"T Laitala","year":"1994","unstructured":"Laitala T, Vaananen HK (1994) Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase. J Clin Invest 93:2311\u20132318","journal-title":"J Clin Invest"},{"key":"583_CR103","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature04535","volume":"440","author":"PF Lange","year":"2006","unstructured":"Lange PF, Wartosch L, Jentsch TJ, Fuhrmann JC (2006) ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440:220\u2013223","journal-title":"Nature"},{"key":"583_CR104","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/nm1514","volume":"12","author":"SH Lee","year":"2006","unstructured":"Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, Kang JS, Miyamoto T, Suda T, Lee SK, Pignolo RJ, Koczon-Jaremko B, Lorenzo J, Choi Y (2006) v-ATPase V(0) subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 12:1403\u20131409","journal-title":"Nat Med"},{"key":"583_CR105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/70563","volume":"23","author":"YP Li","year":"1999","unstructured":"Li YP, Chen W, Liang Y, Li E, Stashenko P (1999) Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23:447\u2013451","journal-title":"Nat Genet"},{"key":"583_CR106","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97:1566\u20131571","journal-title":"Proc Natl Acad Sci USA"},{"key":"583_CR107","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1359\/jbmr.060313","volume":"21","author":"CY Li","year":"2006","unstructured":"Li CY, Jepsen KJ, Majeska RJ, Zhang J, Ni R, Gelb BD, Schaffler MB (2006) Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J Bone Miner Res 21:865\u2013875","journal-title":"J Bone Miner Res"},{"key":"583_CR108","first-page":"115","volume":"21","author":"SC Manolagas","year":"2000","unstructured":"Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115\u2013137","journal-title":"Endocr Rev"},{"key":"583_CR109","doi-asserted-by":"crossref","first-page":"49271","DOI":"10.1074\/jbc.M309914200","volume":"278","author":"MF Manolson","year":"2003","unstructured":"Manolson MF, Yu H, Chen W, Yao Y, Li K, Lees RL, Heersche JN (2003) The a3 isoform of the 100-kDa\u00a0V-ATPase subunit is highly but differentially expressed in large (\u226510 nuclei) and small (\u2264nuclei) osteoclasts. J Biol Chem 278:49271\u201349278","journal-title":"J Biol Chem"},{"key":"583_CR110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1359\/jbmr.071015","volume":"23","author":"B Maranda","year":"2008","unstructured":"Maranda B, Chabot G, Decarie JC, Pata M, Azeddine B, Moreau A, Vacher J (2008) Clinical and cellular manifestations of OSTM1-related infantile osteopetrosis. J Bone Miner Res 23:296\u2013300","journal-title":"J Bone Miner Res"},{"key":"583_CR111","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00223-007-9098-x","volume":"82","author":"DS Margolis","year":"2008","unstructured":"Margolis DS, Szivek JA, Lai LW, Lien YH (2008) Phenotypic Characteristics of Bone in Carbonic Anhydrase II-Deficient Mice. Calcif Tissue Int 82:66\u201376","journal-title":"Calcif Tissue Int"},{"key":"583_CR112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/aja.1001610102","volume":"161","author":"SC Marks Jr","year":"1981","unstructured":"Marks SC Jr, Walker DG (1981) The hematogenous origin of osteoclasts: experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors. Am J Anat 161:1\u201310","journal-title":"Am J Anat"},{"issue":"Suppl 1","key":"583_CR113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01621884","volume":"3","author":"TJ Martin","year":"1993","unstructured":"Martin TJ (1993) Hormones in the coupling of bone resorption and formation. Osteoporos Int 3(Suppl 1):121\u2013125","journal-title":"Osteoporos Int"},{"key":"583_CR114","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/CS20060046","volume":"112","author":"TJ Martin","year":"2007","unstructured":"Martin TJ, Seeman E (2007) New mechanisms and targets in the treatment of bone fragility. Clin Sci (Lond) 112:77\u201391","journal-title":"Clin Sci (Lond)"},{"key":"583_CR115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","volume":"11","author":"TJ Martin","year":"2005","unstructured":"Martin TJ, Sims NA (2005) Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11:76\u201381","journal-title":"Trends Mol Med"},{"key":"583_CR116","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1083\/jcb.151.2.311","volume":"151","author":"M Marzia","year":"2000","unstructured":"Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A (2000) Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 151:311\u2013320","journal-title":"J Cell Biol"},{"key":"583_CR117","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"MR McClung","year":"2006","unstructured":"McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Bekker PJ (2006) Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 354:821\u2013831","journal-title":"N Engl J Med"},{"key":"583_CR118","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1172\/JCI8905","volume":"105","author":"KP McHugh","year":"2000","unstructured":"McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL (2000) Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433\u2013440","journal-title":"J Clin Invest"},{"key":"583_CR119","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1074\/jbc.M608572200","volume":"282","author":"NA Meadows","year":"2007","unstructured":"Meadows NA, Sharma SM, Faulkner GJ, Ostrowski MC, Hume DA, Cassady AI (2007) The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor. J Biol Chem 282:1891\u20131904","journal-title":"J Biol Chem"},{"key":"583_CR120","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1073\/pnas.0401602101","volume":"101","author":"A Mocsai","year":"2004","unstructured":"Mocsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC, Majumdar S, Lanier LL, Lowell CA, Nakamura MC (2004) The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA 101:6158\u20136163","journal-title":"Proc Natl Acad Sci USA"},{"key":"583_CR121","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00223-004-0172-3","volume":"75","author":"MT Mulari","year":"2004","unstructured":"Mulari MT, Qu Q, Harkonen PL, Vaananen HK (2004) Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro. Calcif Tissue Int 75:253\u2013261","journal-title":"Calcif Tissue Int"},{"key":"583_CR122","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","volume":"286","author":"G Mundy","year":"1999","unstructured":"Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946\u20131949","journal-title":"Science"},{"key":"583_CR123","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","volume":"108","author":"K Nakashima","year":"2002","unstructured":"Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17\u201329","journal-title":"Cell"},{"key":"583_CR124","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9440(10)62251-1","volume":"166","author":"S Nataf","year":"2005","unstructured":"Nataf S, Anginot A, Vuaillat C, Malaval L, Fodil N, Chereul E, Langlois JB, Dumontel C, Cavillon G, Confavreux C, Mazzorana M, Vico L, Belin MF, Vivier E, Tomasello E, Jurdic P (2005) Brain and bone damage in KARAP\/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol 166:275\u2013286","journal-title":"Am J Pathol"},{"key":"583_CR125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.276.5310.266","volume":"276","author":"SA Nesbitt","year":"1997","unstructured":"Nesbitt SA, Horton MA (1997) Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276:266\u2013269","journal-title":"Science"},{"key":"583_CR126","doi-asserted-by":"crossref","unstructured":"Neutzsky-Wulff AV, Karsdal MA, Henriksen K (2008) Characterization of the bone phenotype in ClC-7-deficient mice. Calcif Tissue Int (online 29 Oct 2008)","DOI":"10.1007\/s00223-008-9185-7"},{"key":"583_CR127","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1359\/jbmr.1999.14.11.1902","volume":"14","author":"Y Nishi","year":"1999","unstructured":"Nishi Y, Atley L, Eyre DE, Edelson JG, Superti-Furga A, Yasuda T, Desnick RJ, Gelb BD (1999) Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation. J Bone Miner Res 14:1902\u20131908","journal-title":"J Bone Miner Res"},{"key":"583_CR128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.22203\/eCM.v006a05","volume":"6","author":"B Noble","year":"2003","unstructured":"Noble B (2003) Bone microdamage and cell apoptosis. Eur Cell Mater 6:46\u201355","journal-title":"Eur Cell Mater"},{"key":"583_CR129","doi-asserted-by":"crossref","first-page":"C934","DOI":"10.1152\/ajpcell.00234.2002","volume":"284","author":"BS Noble","year":"2003","unstructured":"Noble BS, Peet N, Stevens HY, Brabbs A, Mosley JR, Reilly GC, Reeve J, Skerry TM, Lanyon LE (2003) Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol 284:C934\u2013C943","journal-title":"Am J Physiol Cell Physiol"},{"key":"583_CR130","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.2741\/1750","volume":"10","author":"KU Ogbureke","year":"2005","unstructured":"Ogbureke KU, Zhao Q, Li YP (2005) Human osteopetroses and the osteoclast V\u2013H+-ATPase enzyme system. Front Biosci 10:2940\u20132954","journal-title":"Front Biosci"},{"key":"583_CR131","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","volume":"89","author":"F Otto","year":"1997","unstructured":"Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765\u2013771","journal-title":"Cell"},{"key":"583_CR132","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1359\/jbmr.060403","volume":"21","author":"A Pangrazio","year":"2006","unstructured":"Pangrazio A, Poliani PL, Megarbane A, Lefranc G, Lanino E, Di Rocco M, Rucci F, Lucchini F, Ravanini M, Facchetti F, Abinun M, Vezzoni P, Villa A, Frattini A (2006) Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. J Bone Miner Res 21:1098\u20131105","journal-title":"J Bone Miner Res"},{"key":"583_CR133","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S8756-3282(01)00642-1","volume":"30","author":"AM Parfitt","year":"2002","unstructured":"Parfitt AM (2002) Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30:5\u20137","journal-title":"Bone"},{"key":"583_CR134","doi-asserted-by":"crossref","unstructured":"Pata M, Heraud C, Vacher J (2008) OSTM1 bone defect reveals an intercellular hematopoietic crosstalk. J Biol Chem","DOI":"10.1074\/jbc.M805242200"},{"key":"583_CR135","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1359\/JBMR.040407","volume":"19","author":"P Quarello","year":"2004","unstructured":"Quarello P, Forni M, Barberis L, Defilippi C, Campagnoli MF, Silvestro L, Frattini A, Chalhoub N, Vacher J, Ramenghi U (2004) Severe malignant osteopetrosis caused by a GL gene mutation. J Bone Miner Res 19:1194\u20131199","journal-title":"J Bone Miner Res"},{"key":"583_CR136","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S8756-3282(01)00416-1","volume":"28","author":"V Rajapurohitam","year":"2001","unstructured":"Rajapurohitam V, Chalhoub N, Benachenhou N, Neff L, Baron R, Vacher J (2001) The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation\/function. Bone 28:513\u2013523","journal-title":"Bone"},{"key":"583_CR137","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/humu.20028","volume":"23","author":"A Ramirez","year":"2004","unstructured":"Ramirez A, Faupel J, Goebel I, Stiller A, Beyer S, Stockle C, Hasan C, Bode U, Kornak U, Kubisch C (2004) Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis. Hum Mutat 23:471\u2013476","journal-title":"Hum Mutat"},{"key":"583_CR138","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(98)00183-5","volume":"24","author":"P Ravn","year":"1999","unstructured":"Ravn P, Clemmesen B, Christiansen C (1999a) Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group. Bone 24:237\u2013244","journal-title":"Bone"},{"key":"583_CR139","first-page":"2363","volume":"84","author":"P Ravn","year":"1999","unstructured":"Ravn P, Hosking D, Thompson D, Cizza G, Wasnich RD, McClung M, Yates AJ, Bjarnason NH, Christiansen C (1999b) Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study. J Clin Endocrinol Metab 84:2363\u20132368","journal-title":"J Clin Endocrinol Metab"},{"key":"583_CR140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/excr.1999.4585","volume":"251","author":"FP Reinholt","year":"1999","unstructured":"Reinholt FP, Hultenby K, Heinegard D, Marks SC Jr, Norgard M, Anderson G (1999) Extensive clear zone and defective ruffled border formation in osteoclasts of osteopetrotic (ia\/ia) rats: implications for secretory function. Exp Cell Res 251:477\u2013491","journal-title":"Exp Cell Res"},{"key":"583_CR141","unstructured":"Robey PG, Boskey AL (2006) Extracellular matrix and biomineralization of bone. In: Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th edn, Chap 3, pp 12\u201319"},{"key":"583_CR142","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","volume":"289","author":"GA Rodan","year":"2000","unstructured":"Rodan GA, Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289:1508\u20131514","journal-title":"Science"},{"key":"583_CR143","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0301-472X(99)00061-2","volume":"27","author":"GD Roodman","year":"1999","unstructured":"Roodman GD (1999) Cell biology of the osteoclast. Exp Hematol 27:1229\u20131241","journal-title":"Exp Hematol"},{"key":"583_CR144","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1196\/annals.1346.013","volume":"1068","author":"GD Roodman","year":"2006","unstructured":"Roodman GD (2006) Regulation of osteoclast differentiation. Ann N Y Acad Sci 1068:100\u2013109","journal-title":"Ann N Y Acad Sci"},{"key":"583_CR145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1615\/CritRevEukaryotGeneExpr.v13.i1.30","volume":"13","author":"CJ Rosen","year":"2003","unstructured":"Rosen CJ (2003) The cellular and clinical parameters of anabolic therapy for osteoporosis. Crit Rev Eukaryot Gene Expr 13:25\u201338","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"583_CR146","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00001665-200305000-00007","volume":"14","author":"K Rzeszutek","year":"2003","unstructured":"Rzeszutek K, Sarraf F, Davies JE (2003) Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth. J Craniofac Surg 14:301\u2013307","journal-title":"J Craniofac Surg"},{"key":"583_CR147","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1073\/pnas.95.23.13453","volume":"95","author":"P Saftig","year":"1998","unstructured":"Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95:13453\u201313458","journal-title":"Proc Natl Acad Sci USA"},{"key":"583_CR148","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.micron.2005.06.008","volume":"36","author":"N Sakagami","year":"2005","unstructured":"Sakagami N, Amizuka N, Li M, Takeuchi K, Hoshino M, Nakamura M, Nozawa-Inoue K, Udagawa N, Maeda T (2005) Reduced osteoblastic population and defective mineralization in osteopetrotic (op\/op) mice. Micron 36:688\u2013695","journal-title":"Micron"},{"key":"583_CR149","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1126\/science.276.5310.270","volume":"276","author":"J Salo","year":"1997","unstructured":"Salo J, Lehenkari P, Mulari M, Metsikko K, Vaananen HK (1997) Removal of osteoclast bone resorption products by transcytosis. Science 276:270\u2013273","journal-title":"Science"},{"key":"583_CR150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00003086-197101000-00035","volume":"74","author":"P Sarnsethsiri","year":"1971","unstructured":"Sarnsethsiri P, Hitt OK, Eyring EJ, Frost HM (1971) Tetracycline-based study of bone dynamics in pycnodysostosis. Clin Orthop Relat Res 74:301\u2013312","journal-title":"Clin Orthop Relat Res"},{"key":"583_CR151","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S8756-3282(00)00235-0","volume":"26","author":"ML Sassi","year":"2000","unstructured":"Sassi ML, Eriksen H, Risteli L, Niemi S, Mansell J, Gowen M, Risteli J (2000) Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone 26:367\u2013373","journal-title":"Bone"},{"key":"583_CR152","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1359\/JBMR.040302","volume":"19","author":"S Schaller","year":"2004","unstructured":"Schaller S, Henriksen K, Sveigaard C, Heegaard AM, Helix N, Stahlhut M, Ovejero MC, Johansen JV, Solberg H, Andersen TL, Hougaard D, Berryman M, Shiodt CB, Sorensen BH, Lichtenberg J, Christophersen P, Foged NT, Delaisse JM, Engsig MT, Karsdal MA (2004) The chloride channel inhibitor n53736 prevents bone resorption in ovariectomized rats without changing bone formation. J Bone Miner Res 19:1144\u20131153","journal-title":"J Bone Miner Res"},{"key":"583_CR153","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00198-006-0311-y","volume":"18","author":"AF Schilling","year":"2007","unstructured":"Schilling AF, Mulhausen C, Lehmann W, Santer R, Schinke T, Rueger JM, Amling M (2007) High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K. Osteoporos Int 18:659\u2013669","journal-title":"Osteoporos Int"},{"key":"583_CR154","unstructured":"Schinke T, Schilling AF, Baranowsky A, Huebner A, Schulz A, Zustin J, Gebauer M, Priemel M, Villa A, Teti A, Amling M (2008) Rachitic defects in tcirg1-dependent osteopetrosis are caused by impaired gastric acidification. J Bone Miner Res 21:Suppl 1 (Abstract 1201)"},{"key":"583_CR155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S8756-3282(99)00278-1","volume":"26","author":"JC Scimeca","year":"2000","unstructured":"Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C, Jaillon O, Poirier C, Gaudray P, Carle GF (2000) The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa\u00a0V-ATPase subunit bears a deletion in osteosclerotic (oc\/oc) mutants. Bone 26:207\u2013213","journal-title":"Bone"},{"key":"583_CR156","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD (2006) Bone quality\u2014the material and structural basis of bone strength and fragility. N Engl J Med 354:2250\u20132261","journal-title":"N Engl J Med"},{"key":"583_CR157","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S8756-3282(00)00330-6","volume":"27","author":"I Semba","year":"2000","unstructured":"Semba I, Ishigami T, Sugihara K, Kitano M (2000) Higher osteoclastic demineralization and highly mineralized cement lines with osteocalcin deposition in a mandibular cortical bone of autosomal dominant osteopetrosis type II: ultrastructural and undecalcified histological investigations. Bone 27:389\u2013395","journal-title":"Bone"},{"key":"583_CR158","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/humu.9266","volume":"24","author":"GN Shah","year":"2004","unstructured":"Shah GN, Bonapace G, Hu PY, Strisciuglio P, Sly WS (2004) Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation. Hum Mutat 24:272","journal-title":"Hum Mutat"},{"key":"583_CR159","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1359\/jbmr.2003.18.4.615","volume":"18","author":"IV Silva","year":"2003","unstructured":"Silva IV, Cebotaru V, Wang H, Wang XT, Wang SS, Guo G, Devuyst O, Thakker RV, Guggino WB, Guggino SE (2003) The ClC-5 knockout mouse model of Dent\u2019s disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res 18:615\u2013623","journal-title":"J Bone Miner Res"},{"key":"583_CR160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"583_CR161","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.bi.64.070195.002111","volume":"64","author":"WS Sly","year":"1995","unstructured":"Sly WS, Hu PY (1995) Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64:375\u2013401","journal-title":"Annu Rev Biochem"},{"key":"583_CR162","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1073\/pnas.80.9.2752","volume":"80","author":"WS Sly","year":"1983","unstructured":"Sly WS, Hewett-Emmett D, Whyte MP, Yu YS, Tashian RE (1983) Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 80:2752\u20132756","journal-title":"Proc Natl Acad Sci USA"},{"key":"583_CR163","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/hmg\/10.17.1767","volume":"10","author":"C Sobacchi","year":"2001","unstructured":"Sobacchi C, Frattini A, Orchard P, Porras O, Tezcan I, Andolina M, Babul-Hirji R, Baric I, Canham N, Chitayat D, Dupuis-Girod S, Ellis I, Etzioni A, Fasth A, Fisher A, Gerritsen B, Gulino V, Horwitz E, Klamroth V, Lanino E, Mirolo M, Musio A, Matthijs G, Nonomaya S, Notarangelo LD, Ochs HD, Superti FA, Valiaho J, van Hove JL, Vihinen M, Vujic D, Vezzoni P, Villa A (2001) The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet 10:1767\u20131773","journal-title":"Hum Mol Genet"},{"key":"583_CR164","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ng2076","volume":"39","author":"C Sobacchi","year":"2007","unstructured":"Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, Grabowski P, Del Fattore A, Messina C, Errigo G, Coxon FP, Scott DI, Teti A, Rogers MJ, Vezzoni P, Villa A, Helfrich MH (2007) Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 39:960\u2013962","journal-title":"Nat Genet"},{"key":"583_CR165","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejmg.2007.01.005","volume":"50","author":"N Souraty","year":"2007","unstructured":"Souraty N, Noun P, Djambas-Khayat C, Chouery E, Pangrazio A, Villa A, Lefranc G, Frattini A, Megarbane A (2007) Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis. Eur J Med Genet 50:188\u2013199","journal-title":"Eur J Med Genet"},{"key":"583_CR166","first-page":"437","volume":"15","author":"H Takahashi","year":"1964","unstructured":"Takahashi H, Epker B, Frost HM (1964) Resorption precedes formative activity. Surg Forum 15:437\u2013438","journal-title":"Surg Forum"},{"key":"583_CR167","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9440(10)63798-4","volume":"162","author":"A Taranta","year":"2003","unstructured":"Taranta A, Migliaccio S, Recchia I, Caniglia M, Luciani M, De Rossi G, Dionisi-Vici C, Pinto RM, Francalanci P, Boldrini R, Lanino E, Dini G, Morreale G, Ralston SH, Villa A, Vezzoni P, Del Principe D, Cassiani F, Palumbo G, Teti A (2003) Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol 162:57\u201368","journal-title":"Am J Pathol"},{"key":"583_CR168","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cmet.2007.05.001","volume":"5","author":"S Tatsumi","year":"2007","unstructured":"Tatsumi S, Ishii K, Amizuka N, Li M, Kobayashi T, Kohno K, Ito M, Takeshita S, Ikeda K (2007) Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab 5:464\u2013475","journal-title":"Cell Metab"},{"key":"583_CR169","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1172\/JCI113863","volume":"83","author":"A Teti","year":"1989","unstructured":"Teti A, Blair HC, Teitelbaum SL, Kahn AJ, Koziol C, Konsek J, Zambonin-Zallone A, Schlesinger PH (1989) Cytoplasmic pH regulation and chloride\/bicarbonate exchange in avian osteoclasts. J Clin Invest 83:227\u2013233","journal-title":"J Clin Invest"},{"key":"583_CR170","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1359\/jbmr.1999.14.12.2107","volume":"14","author":"A Teti","year":"1999","unstructured":"Teti A, Migliaccio S, Taranta A, Bernardini S, De Rossi G, Luciani M, Iacobini M, De Felice L, Boldrini R, Bosman C, Corsi A, Bianco P (1999) Mechanisms of osteoclast dysfunction in human osteopetrosis: abnormal osteoclastogenesis and lack of osteoclast-specific adhesion structures. J Bone Miner Res 14:2107\u20132117","journal-title":"J Bone Miner Res"},{"key":"583_CR171","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1210\/endo-97-2-283","volume":"97","author":"ER Thompson","year":"1975","unstructured":"Thompson ER, Baylink DJ, Wergedal JE (1975) Increases in number and size of osteoclasts in response to calcium or phosphorus deficiency in the rat. Endocrinology 97:283\u2013289","journal-title":"Endocrinology"},{"key":"583_CR172","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2007-973550","volume":"29","author":"DA Thompson","year":"1998","unstructured":"Thompson DA, Kriss A, Taylor D, Russell-Eggitt I, Hodgkins P, Morgan G, Vellodi A, Gerritsen EJ (1998) Early VEP and ERG evidence of visual dysfunction in autosomal recessive osteopetrosis. Neuropediatrics 29:137\u2013144","journal-title":"Neuropediatrics"},{"key":"583_CR173","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1056\/NEJMra040952","volume":"351","author":"J Tolar","year":"2004","unstructured":"Tolar J, Teitelbaum SL, Orchard PJ (2004) Osteopetrosis. N Engl J Med 351:2839\u20132849","journal-title":"N Engl J Med"},{"key":"583_CR174","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00214682","volume":"225","author":"VP Tran","year":"1982","unstructured":"Tran VP, Vignery A, Baron R (1982) An electron-microscopic study of the bone-remodeling sequence in the rat. Cell Tissue Res 225:283\u2013292","journal-title":"Cell Tissue Res"},{"issue":"Pt 8","key":"583_CR175","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1242\/jcs.108.8.2729","volume":"108","author":"HK Vaananen","year":"1995","unstructured":"Vaananen HK, Horton M (1995) The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. J Cell Sci 108(Pt 8):2729\u20132732","journal-title":"J Cell Sci"},{"key":"583_CR176","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1615\/CritRevEukaryotGeneExpr.v15.i2.40","volume":"15","author":"L Wesenbeeck Van","year":"2005","unstructured":"Van Wesenbeeck L, Van Hul W (2005) Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology. Crit Rev Eukaryot Gene Expr 15:133\u2013162","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"583_CR177","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI30328","volume":"117","author":"L Wesenbeeck Van","year":"2007","unstructured":"Van Wesenbeeck L, Odgren PR, Coxon FP, Frattini A, Moens P, Perdu B, MacKay CA, Van Hul E, Timmermans JP, Vanhoenacker F, Jacobs R, Peruzzi B, Teti A, Helfrich MH, Rogers MJ, Villa A, Van Hul W (2007) Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J Clin Invest 117:919\u2013930","journal-title":"J Clin Invest"},{"key":"583_CR178","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI6145","volume":"106","author":"L Visentin","year":"2000","unstructured":"Visentin L, Dodds RA, Valente M, Misiano P, Bradbeer JN, Oneta S, Liang X, Gowen M, Farina C (2000) A selective inhibitor of the osteoclastic V\u2013H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats. J Clin Invest 106:309\u2013318","journal-title":"J Clin Invest"},{"key":"583_CR179","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0092-8674(00)81169-1","volume":"93","author":"TH Vu","year":"1998","unstructured":"Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z (1998) MMP-9\/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411\u2013422","journal-title":"Cell"},{"key":"583_CR180","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1210\/jcem.87.5.8497","volume":"87","author":"SG Waguespack","year":"2002","unstructured":"Waguespack SG, Hui SL, White KE, Buckwalter KA, Econs MJ (2002) Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers. J Clin Endocrinol Metab 87:2212\u20132217","journal-title":"J Clin Endocrinol Metab"},{"key":"583_CR181","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1359\/jbmr.2003.18.8.1513","volume":"18","author":"SG Waguespack","year":"2003","unstructured":"Waguespack SG, Koller DL, White KE, Fishburn T, Carn G, Buckwalter KA, Johnson M, Kocisko M, Evans WE, Foroud T, Econs MJ (2003) Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II. J Bone Miner Res 18:1513\u20131518","journal-title":"J Bone Miner Res"},{"key":"583_CR182","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jc.2006-1986","volume":"92","author":"SG Waguespack","year":"2007","unstructured":"Waguespack SG, Hui SL, Dimeglio LA, Econs MJ (2007) Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J Clin Endocrinol Metab 92:771\u2013778","journal-title":"J Clin Endocrinol Metab"},{"key":"583_CR183","doi-asserted-by":"crossref","unstructured":"Walker E, McGregor N, Poulton I, Pompolo S, Allan E, Quinn J, Gillespie M, Martin T, Sims NA (2008) Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J Bone Miner Res","DOI":"10.1359\/jbmr.080706"},{"key":"583_CR184","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1073\/pnas.87.12.4828","volume":"87","author":"W Wiktor-Jedrzejczak","year":"1990","unstructured":"Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER (1990) Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op\/op) mouse. Proc Natl Acad Sci USA 87:4828\u20134832","journal-title":"Proc Natl Acad Sci USA"},{"key":"583_CR185","doi-asserted-by":"crossref","first-page":"20307","DOI":"10.1074\/jbc.M401109200","volume":"279","author":"ZS Xiao","year":"2004","unstructured":"Xiao ZS, Hjelmeland AB, Quarles LD (2004) Selective deficiency of the \u201cbone-related\u201d Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis. J Biol Chem 279:20307\u201320313","journal-title":"J Biol Chem"},{"key":"583_CR186","first-page":"443","volume":"22","author":"J Xu","year":"2007","unstructured":"Xu J, Cheng T, Feng HT, Pavlos NJ, Zheng MH (2007) Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis. Histol Histopathol 22:443\u2013454","journal-title":"Histol Histopathol"},{"key":"583_CR187","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00277-002-0571-3","volume":"82","author":"N Yarali","year":"2003","unstructured":"Yarali N, Fisgin T, Duru F, Kara A (2003) Osteopetrosis and Glanzmann\u2019s thrombasthenia in a child. Ann Hematol 82:254\u2013256","journal-title":"Ann Hematol"},{"key":"583_CR188","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","volume":"139","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329\u20131337","journal-title":"Endocrinology"},{"key":"583_CR189","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","volume":"4","author":"C Zhao","year":"2006","unstructured":"Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K (2006) Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4:111\u2013121","journal-title":"Cell Metab"},{"key":"583_CR190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jbmr.5650080114","volume":"8","author":"MH Zheng","year":"1993","unstructured":"Zheng MH, Fan Y, Wysocki S, Wood DJ, Papadimitriou JM (1993) Detection of mRNA for carbonic anhydrase II in human osteoclast-like cells by in situ hybridization. J Bone Miner Res 8:113\u2013118","journal-title":"J Bone Miner Res"},{"key":"583_CR191","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-0-387-34133-0_28","volume":"585","author":"L Zou","year":"2006","unstructured":"Zou L, Zou X, Li H, Mygind T, Zeng Y, Lu N, Bunger C (2006) Molecular mechanism of osteochondroprogenitor fate determination during bone formation. Adv Exp Med Biol 585:431\u2013441","journal-title":"Adv Exp Med Biol"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-008-0583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00439-008-0583-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-008-0583-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T08:46:23Z","timestamp":1709369183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00439-008-0583-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,6]]},"references-count":191,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1007\/s00439-008-0583-8","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,6]]}}}